These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33453329)

  • 1. Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.
    Giacomelli A; Pagani G; Conti F; Bassoli C; Galli M
    J Hepatol; 2021 Aug; 75(2):484-486. PubMed ID: 33453329
    [No Abstract]   [Full Text] [Related]  

  • 2. HCV point of care screening in people tested for SARS-CoV-2 in a social-housing neighbourhood of Milan, Italy.
    Beltrami M; Pagani G; Conti F; Pezzati L; Casalini G; Rondanin R; Prina A; Zagari A; Galli M; Giacomelli A
    Liver Int; 2023 Jan; 43(1):251-255. PubMed ID: 35869660
    [No Abstract]   [Full Text] [Related]  

  • 3. Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: A cohort study.
    Coppola C; Masarone M; Bartoli M; Staiano L; Coppola R; Torre P; Conforti M; Amoruso D; Gardini I; Persico M
    J Viral Hepat; 2022 Feb; 29(2):171-173. PubMed ID: 34585821
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.
    Torre P; Annunziata M; Sciorio R; Coppola C; Masarone M; Persico M
    Liver Int; 2022 Jun; 42(6):1467-1469. PubMed ID: 35395130
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?
    Crespo J; Díaz-González Á; Cabezas J
    J Hepatol; 2021 Aug; 75(2):486-487. PubMed ID: 33971225
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination.
    Crespo J; Díaz-González Á; Iruzubieta P; Llerena S; Cabezas J
    J Hepatol; 2021 Apr; 74(4):966-967. PubMed ID: 33039405
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
    do Carmo RF; de Souza CDF
    J Hepatol; 2022 Feb; 76(2):470-472. PubMed ID: 34437907
    [No Abstract]   [Full Text] [Related]  

  • 8. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.
    Kondili LA; Aghemo A; Andreoni M; Galli M; Rossi A; Babudieri S; Nava F; Leonardi C; Mennini FS; Gardini I; Russo FP
    Dig Liver Dis; 2022 Feb; 54(2):237-242. PubMed ID: 33926816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is elimination of HCV in 2030 realistic in Central Europe.
    Flisiak R; Zarębska-Michaluk D; Frankova S; Grgurevic I; Hunyady B; Jarcuska P; Kupčinskas L; Makara M; Simonova M; Sperl J; Tolmane I; Vince A
    Liver Int; 2021 Jun; 41 Suppl 1():56-60. PubMed ID: 34155796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.
    Crespo J; Lazarus JV; Iruzubieta P; García F; García-Samaniego J;
    J Hepatol; 2021 Jul; 75(1):224-226. PubMed ID: 33757805
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus micro-elimination: Where do we stand?
    Mangia A; Cotugno R; Cocomazzi G; Squillante MM; Piazzolla V
    World J Gastroenterol; 2021 Apr; 27(16):1728-1737. PubMed ID: 33967553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and schools: what is the risk of contagion? Results of a rapid-antigen-test-based screening campaign in Florence, Italy.
    Bonaccorsi G; Paoli S; Biamonte MA; Moscadelli A; Baggiani L; Nerattini M; Lastrucci V; Zanobini P; Lorini C
    Int J Infect Dis; 2021 Nov; 112():130-135. PubMed ID: 34547492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
    Kondili LA; Blach S; Razavi H; Craxì A
    Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care testing for HCV infection: recent advances and implications for alternative screening.
    Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A
    New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection among the Dental Staff from Lombardy Region, Italy.
    Gallus S; Paroni L; Re D; Aiuto R; Battaglia DM; Crippa R; Carugo N; Beretta M; Balsano L; Paglia L
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33918153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
    Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
    Front Public Health; 2021; 9():628098. PubMed ID: 34249830
    [No Abstract]   [Full Text] [Related]  

  • 20. Health Surveillance and Response to SARS-CoV-2 Mass Testing in Health Workers of a Large Italian Hospital in Verona, Veneto.
    Porru S; Carta A; Monaco MGL; Verlato G; Battaggia A; Parpaiola M; Lo Cascio G; Pegoraro M; Militello V; Moretti F; Tardivo S
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32679773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.